This inventor holds 1 USPTO granted patent and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Vitux Group as. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Steinar Johan Engelsen: Innovator in Pharmaceutical Compositions
Introduction
Steinar Johan Engelsen is a notable inventor based in Tromsø, Norway. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral pharmaceutical compositions. His innovative work has led to the creation of a unique formulation that enhances the delivery of lipophilic drug substances.
Latest Patents
Engelsen holds a patent for "Oral pharmaceutical dispersion compositions." This invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel. The drug substance contains a functional electrostatic group having a pKa value of from 2 to 10. The aqueous carrier has a pH at least 0.3 below or above the pKa value, ensuring optimal drug delivery based on the acidity or basicity of the group.
Career Highlights
Throughout his career, Engelsen has worked with various companies, including Vitux Group and Ayanda Group. His experience in these organizations has allowed him to refine his skills and contribute to advancements in pharmaceutical technology.
Collaborations
Engelsen has collaborated with notable colleagues such as Tore Seternes and Magnus Hattrem. These partnerships have fostered a creative environment that has led to innovative solutions in the pharmaceutical industry.
Conclusion
Steinar Johan Engelsen's contributions to pharmaceutical compositions demonstrate his commitment to innovation and excellence in the field. His patent and collaborations highlight his role as a key figure in advancing drug delivery systems.